BPA Call 36C25919A0043-36C25921N0034
Award Date
10/1/20
Potential Completion Date
9/30/21
Potential Value
$90K
Federal Agency
Veterans Integrated Service Network 19
Awardee
Luminex Corp
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78727, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Luminex Corporation was awarded a $91,000 firm fixed price Blanket Purchase Agreement (BPA) call contract by the Department of Veterans Affairs (VA) to provide Verigene brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2019 under the VA's Master GSA Schedule for In Vitro Diagnostics, Reagents, and Tests, and has a period of performance through September 30, 2020. No set-aside designation was applied to this BPA...
Luminex Corporation has been awarded a firm fixed price blanket purchase agreement (BPA) call contract from the Department of Veterans Affairs (VA) to provide VERIGENE brand reagents and supplies for the Rocky Mountain Regional VA Medical Center. The contract has a potential value of $0.00 and a completion date of September 30th, 2022. It was awarded on October 1st, 2021 under the VA's GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests, with place of performance in Austin,...
The Department of Veterans Affairs (VA) awarded a $31,305.20 firm-fixed price purchase order contract to Luminex Corp for Luminex Verigene Reagents to be delivered to the Louis A. Johnson VA Medical Center in Clarksburg, West Virginia. This contract was awarded as an unrestricted competition through RFQ 36C24523Q1172. The contract has a period of performance through September 30, 2024. Luminex Corp is a manufacturer of biological testing technologies and has a history of providing products and...
This federal contract award is for LUMINEX REAGENTS, provided to the Veterans Integrated Service Network 1 (VISN 1) of the U.S. Department of Veterans Affairs. The $89,432.32 firm fixed price contract was awarded to Luminex Corp, a manufacturer of in-vitro diagnostic testing technologies, on August 1, 2023. The contract is a Blanket Purchase Agreement (BPA) call under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has no set-aside designation and is expected...
Luminex Corporation was awarded a $274,841.80 firm fixed price definitive contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to provide Gram-positive blood culture test kits. The contract has a total small business set aside designation. Performance will occur in Austin, Texas with a completion date of January 25, 2023. As the prime contractor, Luminex will deliver its specialized multiplexing systems and associated assay kits to...
This federal contract award to Luminex Corporation is for the delivery of Luminex reagents under a Blanket Purchase Agreement (BPA) call. The contract, with a ceiling value of $164,760.47, was awarded on August 1, 2021 by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA). The contract is not set aside and is for COVID-19 related requirements, as indicated by the National Interest Action Code. Luminex is a manufacturer of biological...
Luminex Corporation was awarded a $463,944.32 delivery order against the General Services Administration (GSA) Schedule contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The firm fixed price order is for the delivery of Luminex SAR2 test kits to support COVID-19 testing efforts and has a period of performance through November 11, 2021. No set-aside designation was used for this...
The Department of Veterans Affairs awarded a Blanket Purchase Agreement (BPA) call order to Luminex Corp, a manufacturer of biological testing technologies, for REAGENTS AND CONSUMABLES FOR COVID19 TESTING. The $26,937 firm fixed-price contract was awarded on February 1, 2022 through the GSA Schedule for In vitro Diagnostics, Reagents, and Test Kits. The award has an ultimate completion date of July 31, 2022 and does not include a set-aside designation. As a prime contractor, Luminex provides...
Luminex Corporation was awarded a $54,542.40 firm fixed price blanket purchase agreement call against the General Services Administration Federal Supply Schedule contract for Invitro Diagnostics, Reagents, Test (FSS-65-VII). The contract calls for the delivery of reagents and consumables for Luminex multiplexing technology to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1, with performance taking place in North Providence, Rhode Island. No...
The Department of Veterans Affairs Veterans Health Administration awarded a $466,426.44 firm-fixed-price purchase order contract to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies, to provide VERIGENE REGENTS. This contract is not set aside. Luminex is a provider of proprietary multiplex diagnostic solutions, assays, reagents, and related products to government customers including the Department of Veterans Affairs, Centers for Disease Control and...